Skip to content

Member

Anja HAZEKAMP

The Left · Netherlands

Group
The Left
Country
Netherlands
Roll-call participation
51.3 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
85.6 %ⓘ of 3 033 votes where the group had a line · The Left median 92.8 %
More facts (5)
National party
PvdD Partij voor de Dieren
In office
Since 16 Jul 2024
Against clear line
299 of 2 785 votesⓘ
Committees
AGRI (substitute), ENVI (vice-chair), PECH, SANT (substitute)
Member id
125023
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

51.3 %

3 044 of 5 928 roll calls while in office

The Left median: 88.5 % (−37.1 pts)

Chamber median: 90.2 %

With majority line ⓘ

85.6 %

2 595 of 3 033 votes where their group had a line

The Left median: 92.8 % (−7.2 pts)

Against clear line ⓘ

10.7 %

299 of 2 785 votes where their group had a clear line

166 opposite (for ↔ against), 103 abstained against the line, 30 voted for or against when the line was to abstain

Abstention ⓘ

5.6 %

170 of 3 044 votes cast

Participation 51.3 % — The Left median 88.5 %, 47 members.ⓘ
Data as a table
Participation among the 47 members of the The Left with enough votes.
FigureParticipation
Anja HAZEKAMP51.3 %
The Left median88.5 %
Lowest in the group44.2 %
Highest in the group99.3 %
Members47
With majority line 85.6 % — The Left median 92.8 %, 47 members.ⓘ
Data as a table
With majority line among the 47 members of the The Left with enough votes.
FigureWith majority line
Anja HAZEKAMP85.6 %
The Left median92.8 %
Lowest in the group81.9 %
Highest in the group96.9 %
Members47
  • Whole term, 5 928 roll-call votes. The dots are the other members of The Left; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: No vote recorded Majority line: Abstained
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: No vote recorded Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: No vote recorded Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 47 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249292
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202422
22 Oct 20241010
23 Oct 2024129129
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202420
26 Nov 2024180
27 Nov 2024110
28 Nov 2024570
17 Dec 20241313
18 Dec 20243333
19 Dec 20244545
20 Jan 202522
21 Jan 202511
22 Jan 202522
23 Jan 20254545
10 Feb 202511
11 Feb 20253232
12 Feb 20251010
13 Feb 20253030
10 Mar 202522
11 Mar 202599
12 Mar 2025228228
13 Mar 20252424
31 Mar 202530
1 Apr 2025350
2 Apr 20252510
3 Apr 2025620
5 May 202550
6 May 2025100
7 May 20252200
8 May 20251030
21 May 202520
22 May 2025530
16 Jun 202520
17 Jun 2025410
18 Jun 2025910
19 Jun 2025870
7 Jul 202510
8 Jul 2025550
9 Jul 20251340
10 Jul 2025360
8 Sept 202510
9 Sept 20251010
10 Sept 2025340
11 Sept 2025690
6 Oct 202520
7 Oct 202550
8 Oct 2025550
9 Oct 2025650
20 Oct 202530
21 Oct 2025130
22 Oct 20251860
23 Oct 2025550
13 Nov 20252670
24 Nov 202530
25 Nov 2025750
26 Nov 20251000
27 Nov 20251250
15 Dec 202540
16 Dec 2025660
17 Dec 2025430
18 Dec 2025420
20 Jan 2026670
21 Jan 20261120
22 Jan 2026580
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141141
24 Feb 2026430
9 Mar 202611
10 Mar 2026197197
11 Mar 20266059
12 Mar 20263433
25 Mar 202633
26 Mar 20266969
27 Apr 202622
28 Apr 2026225224
29 Apr 2026296296
30 Apr 20266868
18 May 202644
19 May 202633
20 May 20269696
21 May 20269898
15 Jun 202622
16 Jun 20264039
17 Jun 2026127125
18 Jun 20267777
6 Jul 202622
7 Jul 20267272
8 Jul 2026144143
9 Jul 20266767
14 Sept 202611
15 Sept 2026155152
16 Sept 20268079
17 Sept 2026124124

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within The Left

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Martin GÜNTHER The LeftGermany88 % of 1 603 shared87 %
Sebastian EVERDING Former memberThe LeftGermany87 % of 2 552 shared87 %
Jussi SARAMO The LeftFinland86 % of 3 028 shared87 %
Ilaria SALIS The LeftItaly86 % of 2 448 shared87 %
Per CLAUSEN The LeftDenmark86 % of 2 755 shared87 %
Younous OMARJEE The LeftFrance86 % of 2 441 shared87 %
Li ANDERSSON The LeftFinland86 % of 2 707 shared87 %
Merja KYLLÖNEN The LeftFinland86 % of 2 926 shared87 %
Manon AUBRY The LeftFrance85 % of 2 897 shared87 %
Marina MESURE The LeftFrance85 % of 2 989 shared87 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Mélissa CAMARA GreensFrance84 % of 2 443 shared77 %
David CORMAND GreensFrance84 % of 2 947 shared77 %
Saskia BRICMONT GreensBelgium83 % of 2 769 shared77 %
Tilly METZ GreensLuxembourg83 % of 2 848 shared77 %
Marie TOUSSAINT GreensFrance83 % of 2 795 shared77 %
Mounir SATOURI GreensFrance83 % of 2 419 shared77 %
Cristina GUARDA GreensItaly83 % of 2 434 shared77 %
Benedetta SCUDERI GreensItaly82 % of 3 007 shared77 %
Vicent MARZÀ IBÁÑEZ GreensSpain82 % of 3 016 shared77 %
Gordan BOSANAC GreensCroatia81 % of 3 010 shared77 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Agriculture and Rural DevelopmentAGRI CommitteeSubstitute19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeVice-chair20 Jan 2025now
Committee on FisheriesPECH CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with Australia and New ZealandDANZ DelegationSubstitute19 Sept 2024now
Delegation for Northern cooperation and for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary CommitteeDEEA DelegationMember19 Sept 2024now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on LGBTIQ+IG10-16 Intergroup / working groupMember13 May 2026now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Public health aspects of biotechnology and life sciencesShadow rapporteurSANT27 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteur for an opinionENVI20 Apr 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsShadow rapporteurSANT27 Mar 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurSANT12 Mar 2026
Amending Regulation (EU) No 528/2012 as regards the extension of certain data protection periodsShadow rapporteurENVI12 Mar 2026
Amending Council Directive 98/58/EC and Directive 2009/128/EC of the European Parliament and of the Council as regards the simplification and strengthening of food and feed safety requirements, and repealing Council Directives 82/711/EEC and 85/572/EECShadow rapporteurENVI12 Mar 2026
Amending Regulations (EC) No 999/2001, (EC) No 1829/2003, (EC) No 1831/2003, (EC) No 852/2004, (EC) No 853/2004, (EC) No 396/2005, (EC) No 1099/2009, (EC) No 1107/2009, (EU) No 528/2012, (EU) 2017/625 as regards the simplification and strengthening of food and feed safety requirementsShadow rapporteurENVI12 Mar 2026
Amending Council Directive 98/58/EC and Directive 2009/128/EC of the European Parliament and of the Council as regards the simplification and strengthening of food and feed safety requirements, and repealing Council Directives 82/711/EEC and 85/572/EECShadow rapporteurAGRI3 Mar 2026
Amending Regulations (EC) No 999/2001, (EC) No 1829/2003, (EC) No 1831/2003, (EC) No 852/2004, (EC) No 853/2004, (EC) No 396/2005, (EC) No 1099/2009, (EC) No 1107/2009, (EU) No 528/2012, (EU) 2017/625 as regards the simplification and strengthening of food and feed safety requirementsShadow rapporteurAGRI3 Mar 2026
Amending Regulation (EU) No 1308/2013 as regards the school fruit, vegetables and milk scheme (‘EU school scheme’), sectoral interventions, the creation of a protein sector, requirements for hemp, the possibility for marketing standards for cheese, protein crops and meat, application of additional import duties, rules on the availability of supplies in time of emergencies and severe crisis and securitiesShadow rapporteurAGRI3 Mar 2026

Show all 28 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

16 contributions recorded; 5 on behalf of their group; 21 minutes of speaking time.

Show all 16 recent contributions

Questions and motions, 124

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
11 Sept 2026MOTION FOR A RESOLUTION on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products B-10-2026-0392Motion for a resolutionwith 3 co-authors—
10 Sept 2026EU exports of banned pesticides E-10-2026-003605Written questionwith 35 co-authorsNot yet answered
8 Sept 2026Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539Written questionwith 67 co-authorsNot yet answered
7 Sept 2026Climate change, public health and the world of work: for a directive on maximum working temperatures O-10-2026-000035Oral questionwith 35 co-authorsNot yet answered
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0379Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0380Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0381Motion for a resolutionwith 3 co-authors—
11 Aug 2026Animal welfare in Uganda in the context of EU development cooperation E-10-2026-003257Written questionwith 1 co-authorNot yet answered
14 Jul 2026Irregularities relating to the validation of the European Citizens’ Initiative ‘Stop Cruelty Stop Slaughter’ E-10-2026-002926Written questionwith 1 co-author15 Sept 2026

Show all 124 questions and motions

Amendments tabled in committee, 93

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ6424
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ6436
20 Jul 2026Amending Directives 2008/98/EC, 2010/75/EU, (EU) 2015/2193 and (EU) 2024/1785 of the European Parliament and of the Council as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790834 ENVI1
15 Jul 2026Amending Regulation (EU) 2023/1542 and Regulation (EU) 2024/1244 as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790846 ENVI1
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790958 AGRI8
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790956 AGRI7
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790957 AGRI9
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ538
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790899 AGRI21
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ5318

Show all 93 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political groups this term

National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Anja HAZEKAMP”. Member record. memberId 125023. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/125023?nb=all&page=77&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/125023. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/125023?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-125023,
  author = {{EU Parl Watch Research}},
  title = {{Anja HAZEKAMP}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/125023?nb=all&page=77&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/125023?nb=all&page=77&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 125023. Official source: https://www.europarl.europa.eu/meps/en/125023. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}